Applied Therapeutics

Warning Letter FDA Warning Letter FDA
Biotech

FDA chides Applied Therapeutics' trial conduct in warning letter

While Applied Therapeutics plans to appeal a recent rejection of govorestat, issues with the biotech’s clinical conduct could hamper those plans.
Fraiser Kansteiner Dec 4, 2024 11:21am
Graphic image of a red thumbs down against a blue background

FDA rejects Applied filing for rare disease approval

Dec 2, 2024 5:27am
FDA

FDA scraps adcomm for Applied's rare disease drug

Sep 18, 2024 8:00am
delay FDA delay

Applied Tx’s pediatric rare disease prosect hits another snag

Mar 29, 2024 10:21am
sword fight onward path sunset sun rise

Applied claims victory in phase 3 SORD fight, plots path to FDA

Feb 15, 2024 10:10am
parachute sunset flying

Scorpion taps new CEO, CMO—Chutes & Ladders

Jan 5, 2024 9:30am